Arkolith/Insider Trading/NBP/Form 4

Xu Cong Claire

SVP, Clinical DevelopmentNovaBridge Biosciences (NBP) · full profile →Form 4 · filed Jul 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 6, 2026Sell(S)4K$0.89$4K298K
Jul 4, 2026Option exercise(M)12K——303K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 4, 2026Option exercise(M)5K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002114309-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML